Wegovy is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or with overweight plus a weight-related condition
These problems were often linked to nausea, vomiting, diarrhea, or dehydration
Dermatology Research and Practice, 2024 , 5551774.
Because its a long-term medication, we will typically adjust the dose monthly
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes management, has emerged as a treatment option for chronic weight management in adults with obesity or overweight conditions
Despite this flurry of announcements, industry leaders caution that expanded capacity will be gradual